---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-092491"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2024-08-23T23:59:59+00:00"
generated_at: "2026-05-31T07:51:01.565815+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics receives Nasdaq non-compliance notice for late Form 10-Q filing

## Summary
- Nasdaq notice on Aug 21, 2024, for failure to timely file Q2 2024 Form 10-Q.
- Company has 60 days (until Oct 21, 2024) to submit compliance plan; possible extension to Feb 17, 2025.
- Forvis Mazars resigned as auditor on Aug 9, 2024; company seeking new independent accounting firm.
- Notice has no immediate effect on Nasdaq listing, but delisting risk if compliance not regained.

## SEC filing metadata
- accession: 0001104659-24-092491
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2024-08-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465924092491/0001104659-24-092491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465924092491/tm2422567d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-092491
- JSON: https://secwatch.observer/filing/0001104659-24-092491.json
- Plain text: https://secwatch.observer/filing/0001104659-24-092491.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.